This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaborowska, I.
Right arrow Articles by Walsh, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaborowska, I.
Right arrow Articles by Walsh, D.

 Previous Article  |  Next Article 

Journal of Virology, April 2009, p. 3988-3992, Vol. 83, No. 8
0022-538X/09/$08.00+0     doi:10.1128/JVI.02284-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

PI3K Signaling Regulates Rapamycin-Insensitive Translation Initiation Complex Formation in Vaccinia Virus-Infected Cells{triangledown}

Izabela Zaborowska and Derek Walsh*

National Institute for Cellular Biotechnology, Dublin City University, Dublin 9, Ireland

Received 31 October 2008/ Accepted 1 February 2009

How vaccinia virus (VV) regulates assembly of the host translation initiation complex eIF4F remains unclear. Here, we show that VV activated host PI3K to stimulate downstream mammalian target of rapamycin (mTOR), a kinase that inactivates the translational repressor 4E-BP1. However, although the mTOR inhibitor rapamycin suppressed VV-induced inactivation of 4E-BP1, it failed to inhibit eIF4F assembly. In contrast, PI3K inhibition in VV-infected cells increased the abundance of hypophosphorylated 4E-BP1 and disrupted eIF4F complex formation. PI3K signaling, therefore, plays a critical role in regulating protein production during VV infection, at least in part by controlling the abundance and activity of 4E-BP1.


* Corresponding author. Mailing address: National Institute for Cellular Biotechnology, Dublin City University, Dublin 9, Ireland. Phone: 353-1-7006260. Fax: 353-1-7005484. E-mail: derek.walsh{at}dcu.ie

{triangledown} Published ahead of print on 11 February 2009.


Journal of Virology, April 2009, p. 3988-3992, Vol. 83, No. 8
0022-538X/09/$08.00+0     doi:10.1128/JVI.02284-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Dunn, E. F., Fearns, R., Connor, J. H. (2009). Akt Inhibitor Akt-IV Blocks Virus Replication through an Akt-Independent Mechanism. J. Virol. 83: 11665-11672 [Abstract] [Full Text]